<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6771736/results/search/disease/results.xml">
  <result pre="CCBs Calcium channel blockers cGMP Cyclic guanosine monophosphate CHD Congenital" exact="heart disease" post="EMA European Medicines Agency ERAs Endothelin receptor antagonists FDA"/>
  <result pre="pulmonary arterial hypertension (PAH) (Group 1), PH due to left" exact="heart disease" post="(Group 2), PH due to lung diseases and/or hypoxia"/>
  <result pre="due to lung diseases and/or hypoxia (Group 3), chronic thromboembolic" exact="pulmonary hypertension" post="(Group 4), and PH with unclear and/or multifactorial mechanisms"/>
  <result pre="(PVR) ≥3 Wood units × m 2 (≈240 dyn s cm –5), in the absence of" exact="lung disease" post="and Group 4 or 5 PH. 1, 2, 3"/>
  <result pre="a new definition for Group 4 to include chronic thromboembolic" exact="pulmonary hypertension" post="(CTEPH) and other pulmonary artery obstructions. 1, 3 1.1"/>
  <result pre="accounts for the majority of cases, and PH associated with" exact="lung disease" post="(Group 3), of which the most common form is"/>
  <result pre="PAH in children are idiopathic (iPAH), heritable gene defects, and" exact="congenital heart disease" post="(CHD); however, connective tissue disease, human immunodeficiency virus, drugs,"/>
  <result pre="in children are idiopathic (iPAH), heritable gene defects, and congenital" exact="heart disease" post="(CHD); however, connective tissue disease, human immunodeficiency virus, drugs,"/>
  <result pre="study in 50 children (age, 2 mo‐2 y) with high‐altitude" exact="heart disease" post="and severe PAH Sildenafil 1 mg/kg/day • Sildenafil reduced mPAP"/>
  <result pre="Retrospective chart review of 25 children (age, &amp;lt;2 y) with chronic" exact="lung disease" post="and PH 1.5–8.0 mg/kg/day • Hemodynamic improvement in 88% of"/>
  <result pre="(62‐46 mm Hg; P = .041) Abbreviations: 6MWD, 6‐minute walking distance; CHD," exact="congenital heart disease;" post="CI, confidence interval; FC, functional class; hPAH, heritable pulmonary"/>
  <result pre="mm Hg; P = .041) Abbreviations: 6MWD, 6‐minute walking distance; CHD, congenital" exact="heart disease;" post="CI, confidence interval; FC, functional class; hPAH, heritable pulmonary"/>
  <result pre="NYHA, New York Heart Association; PAH, pulmonary arterial hypertension; PH," exact="pulmonary hypertension;" post="pO 2, partial pressure of oxygen; PVO 2, peak"/>
  <result pre=", et al. Haemodynamic definitions and updated clinical classification of" exact="pulmonary hypertension." post="Eur Respir J. 2019; 53: 1801913. 30545968 4 Berger"/>
  <result pre=", Roofthooft MT , Hillege HL , et al. Pediatric" exact="pulmonary hypertension" post="in The Netherlands: Epidemiology and characterization during the period"/>
  <result pre="JD , Romer LH . Trends in hospitalization for pediatric" exact="pulmonary hypertension." post="Pediatrics. 2015; 136: 241‐ 250. 26148956 12 Vorhies EE"/>
  <result pre="12 Vorhies EE , Ivy DD . Drug treatment of" exact="pulmonary hypertension" post="in children. Paediatr Drugs. 2014; 16: 43‐ 65. 24114695"/>
  <result pre="Badesch D , Gibbs JSR , et al. Diagnosis of" exact="pulmonary hypertension." post="Eur Respir J. 2019; 53: 1801904. 30545972 14 Beghetti"/>
  <result pre=", Schulze‐Neick I , et al. Diagnostic evaluation of paediatric" exact="pulmonary hypertension" post="in current clinical practice. Eur Respir J. 2013; 42:"/>
  <result pre="Expert consensus statement on the diagnosis and treatment of paediatric" exact="pulmonary hypertension." post="The European Paediatric Pulmonary Vascular Disease Network, endorsed by"/>
  <result pre="IR . Right heart catheterisation: Best practice and pitfalls in" exact="pulmonary hypertension." post="Eur Respir Rev. 2015; 24: 642‐ 652. 26621978 17"/>
  <result pre="Hemodynamic and genetic analysis in children with idiopathic, heritable, and" exact="congenital heart disease" post="associated pulmonary arterial hypertension . Respir Res. 2013; 14:"/>
  <result pre="and genetic analysis in children with idiopathic, heritable, and congenital" exact="heart disease" post="associated pulmonary arterial hypertension . Respir Res. 2013; 14:"/>
  <result pre="Apitz C , Michel‐Behnke I. Pulmonary hypertension in children with" exact="congenital heart disease" post="(PAH‐CHD, PPHVD‐CHD). Expert consensus statement on the diagnosis and"/>
  <result pre="C , Michel‐Behnke I. Pulmonary hypertension in children with congenital" exact="heart disease" post="(PAH‐CHD, PPHVD‐CHD). Expert consensus statement on the diagnosis and"/>
  <result pre="Expert consensus statement on the diagnosis and treatment of paediatric" exact="pulmonary hypertension." post="The European Paediatric Pulmonary Vascular Disease Network, endorsed by"/>
  <result pre=", et al. Genetic testing and blood biomarkers in paediatric" exact="pulmonary hypertension." post="Expert consensus statement on the diagnosis and treatment of"/>
  <result pre="Expert consensus statement on the diagnosis and treatment of paediatric" exact="pulmonary hypertension." post="The European Paediatric Pulmonary Vascular Disease Network, endorsed by"/>
  <result pre="and survival in children with pulmonary arterial hypertension: the UK" exact="pulmonary hypertension" post="service for children 2001‐2006 . Heart. 2009; 95: 312‐"/>
  <result pre="al. Clinical classification in pediatric pulmonary arterial hypertension associated with" exact="congenital heart disease" post=". Pulm Circ. 2016; 6: 302‐ 312. 27683607 27"/>
  <result pre="Clinical classification in pediatric pulmonary arterial hypertension associated with congenital" exact="heart disease" post=". Pulm Circ. 2016; 6: 302‐ 312. 27683607 27"/>
  <result pre=", Abman SH , Barst RJ , et al. Pediatric" exact="pulmonary hypertension." post="J Am Coll Cardiol. 2013; 62: D117‐ D126. 24355636"/>
  <result pre="SP , Howard LS , et al. Treatment goals of" exact="pulmonary hypertension." post="J Am Coll Cardiol. 2013; 62: D73‐ D81. 24355644"/>
  <result pre=", Rubin LJ , Simonneau G. Improving patient outcomes in" exact="pulmonary hypertension." post="Eur Respir Rev. 2015; 24: 550‐ 551. 26621969 39"/>
  <result pre="imbalance between the excretion of thromboxane and prostacyclin metabolites in" exact="pulmonary hypertension" post=". N Engl J Med. 1992; 327: 70‐ 75."/>
  <result pre="synthase expression is decreased in lungs from patients with severe" exact="pulmonary hypertension" post=". Am J Respir Crit Care Med. 1999; 159:"/>
  <result pre=", Maislin G , Fishman AP . Vasodilator therapy for" exact="primary pulmonary hypertension" post="in children. Circulation. 1999; 99: 1197‐ 1208. 10069788 45"/>
  <result pre="Maislin G , Fishman AP . Vasodilator therapy for primary" exact="pulmonary hypertension" post="in children. Circulation. 1999; 99: 1197‐ 1208. 10069788 45"/>
  <result pre="of subcutaneous treprostinil infusions in the treatment of severe pediatric" exact="pulmonary hypertension" post=". Int J Cardiol. 2018; 264: 153‐ 157. 29650343"/>
  <result pre=", Beghetti M. Inhaled iloprost for the control of acute" exact="pulmonary hypertension" post="in children: a systematic review . Pediatr Crit Care"/>
  <result pre=", Haworth SG . Response to bosentan in children with" exact="pulmonary hypertension." post="Heart. 2006; 92: 664‐ 670. 16216850 53 Beghetti M"/>
  <result pre=", Osterloh IH , Grimminger F. Sildenafil: from angina to" exact="erectile dysfunction" post="to pulmonary hypertension and beyond. Nat Rev Drug Discov."/>
  <result pre=", Grimminger F. Sildenafil: from angina to erectile dysfunction to" exact="pulmonary hypertension" post="and beyond. Nat Rev Drug Discov. 2006; 5: 689‐"/>
  <result pre="responses to oral sildenafil during invasive testing in children with" exact="pulmonary hypertension" post=". J Am Coll Cardiol. 2010; 55: 1456‐ 1462."/>
  <result pre="The role of preoperative sildenafil therapy in controlling of postoperative" exact="pulmonary hypertension" post="in children with ventricular septal defects . J Cardiovasc"/>
  <result pre="the tolerability of intermittent intravenous sildenafil in pediatric patients with" exact="pulmonary hypertension" post=". J Pediatr Pharmacol Ther. 2016; 21: 419‐ 425."/>
  <result pre="R , Russolillo V , et al. Sildenafil therapy for" exact="pulmonary hypertension" post="before and after pediatric congenital heart surgery . Tex"/>
  <result pre="with pulmonary arterial hypertension associated with the different types of" exact="congenital heart disease" post=". Clin Cardiol. 2011; 34: 513‐ 518. 21678455 75"/>
  <result pre="pulmonary arterial hypertension associated with the different types of congenital" exact="heart disease" post=". Clin Cardiol. 2011; 34: 513‐ 518. 21678455 75"/>
  <result pre="safety of oral sildenafil in children with Down syndrome and" exact="pulmonary hypertension" post=". BMC Cardiovasc Disord. 2017; 17: 177. 28676038 78"/>
  <result pre="and safety of sildenafil in the treatment of high altitude" exact="heart disease" post="associated with severe pulmonary arterial hypertension in children: A"/>
  <result pre=". Safety and efficacy of sildenafil therapy in children with" exact="pulmonary hypertension." post="Int J Cardiol. 2005; 100: 267‐ 273. 15823634 81"/>
  <result pre=", Abman SH . Effects of long‐term sildenafil treatment for" exact="pulmonary hypertension" post="in infants with chronic lung disease . J Pediatr."/>
  <result pre="long‐term sildenafil treatment for pulmonary hypertension in infants with chronic" exact="lung disease" post=". J Pediatr. 2009; 154: 379‐ 384. 384 e371‐372."/>
  <result pre="JP , Evgenov OV . Soluble guanylate cyclase stimulators in" exact="pulmonary hypertension." post="Handb Exp Pharmacol. 2013; 218: 279‐ 313. 24092345 97"/>
  <result pre="acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in" exact="pulmonary hypertension" post=". Eur Respir J. 2009; 33: 785‐ 792. 19129292"/>
  <result pre="al. Clinical trials in neonates and children: Report of the" exact="pulmonary hypertension" post="academic research consortium pediatric advisory committee . Pulm Circ."/>
 </snippets>
</snippetsTree>
